Translucence Biosystems Participates in Keystone Meeting on Drug Delivery to the Brain
Join Translucence Biosystems at the Keystone Symposium: Drug Delivery to the Brain on Jan 23-26th
Join
Read More
Translucence Biosystems Sponsors 20th Annual Advanced Imaging Methods Workshop
Translucence Biosystems is Attending the 20th Annual Advanced Imaging Methods Workshop on Jan 24-26th
Join
Read More

Fast and reliable 3D analysis of biological samples

This is more than just microscopy — this is a revolutionary system of cutting-edge tools and technologies for next-generation 3D histology.

We are enabling the dimensional shift from 2D to 3D tissue histology, developing tissue clearing methods, assays, imaging technology, machine learning-enabled data processing tools and novel methods for big data statistical analysis of spatial anatomy.

Increase access to the intricate 3D structure of the brain and other complex organs with powerful workflows

unique expertise in tissue clearing

light sheet imaging with our Mesoscale imaging System™

Pipeline for computational 3D reconstruction

Machine learning-based image analysis

Learn more

Imagine entire 3D cell cultures which preserve structural integrity by combining with tissue clearing methods

See examples

Our services

Whole-brain assays

neuronal activity

neuroinflammation

β-amyloid

More info

Custom services

clearing

tissue imaging

tissue quantification

More info

Latest research and news

January 31, 2023
Updates

Translucence Biosystems Sponsors 20th Annual Advanced Imaging Methods Workshop

Translucence Biosystems was proud to sponsor the 20th Annual Advanced Imaging Methods Workshop, an event that brought together researchers and industry leaders to share the latest advancements in imaging technology.
by
Translucence Biosystems
January 31, 2023
Updates

Translucence Biosystems Participates in Keystone Meeting on Drug Delivery to the Brain

Our team has been working with Lundbeck to monitor therapeutic antibody biodistribution in the brain using tissue clearing and light sheet imaging. Our CEO, Damian Wheeler, Ph.D. presented our findings in our poster titled the "Brain-Wide Cellular-Resolution Measurement of Antibody Therapeutics."
by
Translucence Biosystems
November 13, 2022
Research

Translucence Biosystems Presents at SfN 2022

The Translucence team, including Nate Guanzon, Chase Redd, and CEO Damian Wheeler presented our BRAIN Initiative-funded work on whole-brain quantification neuronal activity with Npas4 and cFos at SfN 2022.
by
Translucence Biosystems

Ask your question

Send us your questions and we will get back to you as soon as possible
info@translucencebio.com

Thank you! Your submission has been received!
Something went wrong while submitting the form.
Please, contact via us direct email info@translucencebio.comand